SpeechPathology.com Phone: 800-242-5183


eLuma Online Therapy - Own Boss - May 2023

Infection Control for Methicillin-Resistant Staphylococcus (MRSA)

A. Bankaitis, Ph.D

March 10, 2008

Share:

Question

I recently read about a case of Staphylococcus at my child's school. Upon further research on the internet, I have seen news reports that there are "resistant" forms of this bacterium that are causing issues in the US and abroad. I follow general infect

Answer

The recent outbreak of methicillin-resistant Staphylococcus aureus (MRSA) serves as a reminder to speech-language pathologists of the importance of infection control in the clinical environment. MRSA is a type of bacterium resistant to certain antibiotics including methicillin, penicillin, and amoxicillin (CDC, 2007). In the past, this genetic mutation of Staphylococcus has typically manifested as a nosocomial infection (i.e. hospital or health-care facility acquired); apparently, it has found its way into the general population.

The main mode of MRSA transmission is through direct or indirect contact with the hands. Hand hygiene is the single most important activity that audiologists can do to minimize the potential spread of MRSA. Washing hands with liquid, medical grade soap and water must occur immediately prior to the patient appointment, throughout the patient appointment as needed, immediately upon the removal of gloves, and at the end of the patient appointment. If access to a sink with running water is not available, the use of no-rinse hand degermers serves as an appropriate alternative to traditional hand washing. Beyond hand hygiene, speech-language pathologists are legally and ethically obligated to uphold the federally mandated infection control standards issued by the Centers for Disease Control and Prevention (CDC) and formalized by the Occupational Safety and Health Administration (OSHA).

For more detailed information, speech-language pathologists are referred to the resource "Infection Control for Speech-Language Pathology" by Bankaitis, Kemp, Krival, and Bandaranayake. This book may be ordered through Oaktree Products toll free at 800.347.1960.

References

CDC (2007) Healthcare-associated methicillin resistant Staphylococcus aureus (HA-MRSA). Available: www.cdc.gov/

Bankaitis, A.U., Kemp, R.J., Krival, K., Bandaranayake, D. (2005). Infection Control for Speech-Language Pathology, St. Louis, MO: Auban, Inc.

A.U. Bankaitis is Vice President and General Manager of Oaktree Products. She is an audiologist with a niche expertise in the area of infection control as it pertains to the professionals of audiology and speech-language pathology.


a bankaitis

A. Bankaitis, Ph.D


Related Courses

Treatment Approach Considerations for School-Aged Children with Speech Sound Disorders
Presented by Kathryn Cabbage, PhD, CCC-SLP
Video

Presenter

Kathryn Cabbage, PhD, CCC-SLP
Course: #9472Level: Intermediate1 Hour
  'Good review of strategies like the Principles of Motor Learning'   Read Reviews
This course will address the theoretical underpinnings and research base related to differential diagnosis and treatment of articulation and phonological deficits in children with speech sound disorders. Special considerations for how to tailor evaluation and intervention to meet the needs of school-age children will be discussed.

The Ripple Effect of Stuttering: A Community-Based Approach
Presented by Craig Coleman, MA, CCC-SLP, BCS-F, ASHA Fellow, Mary Weidner, PhD, CCC-SLP
Video

Presenters

Craig Coleman, MA, CCC-SLP, BCS-F, ASHA FellowMary Weidner, PhD, CCC-SLP
Course: #9217Level: Intermediate2 Hours
  'I appreciate all the goal examples, and explaining where to start treatment depending on where they are in their understanding of stuttering and why'   Read Reviews
This is Part 2 of a four-part series. The stuttering experience has a ripple effect that extends far beyond the child who stutters. Parents, teachers, peers, and others must possess both knowledge and skills to best support children who stutter. This course will highlight new clinical tools and resources to provide a community-based treatment approach for stuttering. (Part 1 - Course 9278, Part 3 - Course 9301, Part 4 - Course 9304)

Behavioral Frameworks for Dementia Management
Presented by Mary Beth Mason, PhD, CCC-SLP, Robert W. Serianni, MS, CCC-SLP, FNAP
Video

Presenters

Mary Beth Mason, PhD, CCC-SLPRobert W. Serianni, MS, CCC-SLP, FNAP
Course: #9473Level: Intermediate1 Hour
  'Instructors provided detailed examples and researched information'   Read Reviews
This course will focus on cognitive-communication intervention strategies for various dementia presentations and will provide a review of evidence-based treatment. Behavioral frameworks along with their rationales will be introduced and applied across several dementia types and mild, moderate and severe levels of impairment.

20Q: Infection Control Strategies for SLPs
Presented by A.U. Bankaitis Smith, PhD
Text

Presenter

A.U. Bankaitis Smith, PhD
Course: #9729Level: Intermediate1 Hour
  'Clarification of COVID precautionary information'   Read Reviews
Speech-language pathologists are expected by policy authorities to apply appropriate measures to protect patients, co-workers and themselves in clinical situations that may expose individuals to infectious microbes. This article provides practical guidelines for implementing infection control principles within the context of the COVID-19 pandemic, including discussion of personal protective equipment (PPE) and disinfecting and cleaning products.

Thickened Liquids in Clinical Practice: The Plot “Thickens”
Presented by Angela Mansolillo, MA, CCC-SLP, BCS-S
Video

Presenter

Angela Mansolillo, MA, CCC-SLP, BCS-S
Course: #10497Level: Intermediate1 Hour
  'I work in the acute care setting and found this course extremely helpful'   Read Reviews
Clinicians who utilize thickened liquids in their clinical practice are aware of their benefits, but what about the risks and contraindications? Advantages and disadvantages of thickened liquids are reviewed in this course with a focus on clinical outcomes, including impacts on medication administration, lung health, and hydration. Product types are evaluated to facilitate appropriate choices for individual clients.

Our site uses cookies to improve your experience. By using our site, you agree to our Privacy Policy.